# A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults

> **NCT06375772** · PHASE2 · TERMINATED · sponsor: **G.ST Antivirals GmbH** · enrollment: 64 (actual)

## Conditions studied

- Acute Nasopharyngitis

## Interventions

- **DRUG:** 2-Deoxy-D-glucose
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06375772
- **Lead sponsor:** G.ST Antivirals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-04-02
- **Primary completion:** 2024-08-13
- **Final completion:** 2024-08-13
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** Re-calculated sample size
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375772, "A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06375772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*